Anni Aggerholm

1.6k total citations
38 papers, 1.2k citations indexed

About

Anni Aggerholm is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Anni Aggerholm has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 25 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Anni Aggerholm's work include Acute Myeloid Leukemia Research (26 papers), Epigenetics and DNA Methylation (17 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Anni Aggerholm is often cited by papers focused on Acute Myeloid Leukemia Research (26 papers), Epigenetics and DNA Methylation (17 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Anni Aggerholm collaborates with scholars based in Denmark, Sweden and Norway. Anni Aggerholm's co-authors include Per Guldberg, Peter Hokland, Lene Olesen, Jesper Worm, Mette Skov Holm, Marianne Hokland, Lene Hyldahl Ebbesen, Kirsten Grønbæk, Eigil Kjeldsen and Charlotte Guldborg Nyvold and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Anni Aggerholm

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anni Aggerholm Denmark 18 824 595 175 139 109 38 1.2k
Françoise Birg France 19 684 0.8× 360 0.6× 177 1.0× 82 0.6× 115 1.1× 34 1.2k
H G Drexler Germany 17 318 0.4× 324 0.5× 157 0.9× 60 0.4× 44 0.4× 26 810
Lori Jerome Canada 11 739 0.9× 248 0.4× 33 0.2× 143 1.0× 134 1.2× 18 979
HG Drexler Germany 12 326 0.4× 187 0.3× 86 0.5× 72 0.5× 67 0.6× 15 712
Diane Giannola United States 11 345 0.4× 198 0.3× 54 0.3× 76 0.5× 121 1.1× 18 665
Marja van Meijer Netherlands 13 453 0.5× 290 0.5× 65 0.4× 224 1.6× 232 2.1× 18 919
Francesca Guerrini Italy 14 182 0.2× 205 0.3× 121 0.7× 55 0.4× 86 0.8× 31 537
Louis van de Locht Netherlands 7 388 0.5× 191 0.3× 40 0.2× 58 0.4× 57 0.5× 9 641
Lene Udby Denmark 17 278 0.3× 134 0.2× 94 0.5× 101 0.7× 131 1.2× 25 829

Countries citing papers authored by Anni Aggerholm

Since Specialization
Citations

This map shows the geographic impact of Anni Aggerholm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anni Aggerholm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anni Aggerholm more than expected).

Fields of papers citing papers by Anni Aggerholm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anni Aggerholm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anni Aggerholm. The network helps show where Anni Aggerholm may publish in the future.

Co-authorship network of co-authors of Anni Aggerholm

This figure shows the co-authorship network connecting the top 25 collaborators of Anni Aggerholm. A scholar is included among the top collaborators of Anni Aggerholm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anni Aggerholm. Anni Aggerholm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aggerholm, Anni, Gitte Kerndrup, Lene Hyldahl Ebbesen, et al.. (2022). Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantation. Bone Marrow Transplantation. 57(3). 460–465. 11 indexed citations
2.
Lausen, Birgitte, Linda Holmfeldt, Anni Aggerholm, et al.. (2021). Measurable Residual Disease Monitoring of SPAG6, ST18, PRAME, and XAGE1A Expression in Peripheral Blood May Detect Imminent Relapse in Childhood Acute Myeloid Leukemia. Journal of Molecular Diagnostics. 23(12). 1787–1799. 3 indexed citations
3.
Browne, Patrick Denis, Tue Kjærgaard Nielsen, Witold Kot, et al.. (2020). GC bias affects genomic and metagenomic reconstructions, underrepresenting GC-poor organisms. GigaScience. 9(2). 105 indexed citations
4.
Hansen, Marcus Høy, Eigil Kjeldsen, Peter Möller, et al.. (2018). Systematic evaluation of signal-to-noise ratio in variant detection from single cell genome multiple displacement amplification and exome sequencing. BMC Genomics. 19(1). 681–681. 11 indexed citations
5.
Ebbesen, Lene Hyldahl, et al.. (2018). Skewed ratio between type 1 and type 2 calreticulin mutations in essential thrombocytosis patients with concomitant Janus kinase 2 V617F mutation. Experimental Hematology. 68. 62–65. 7 indexed citations
6.
Kjeldsen, Eigil, et al.. (2018). Congenital hypoplastic bone marrow failure associated with a de novo partial deletion of the MECOM gene at 3q26.2. Gene. 656. 86–94. 11 indexed citations
7.
Hansen, Marcus Høy, Judit Jørgensen, Anni Aggerholm, et al.. (2014). Delineation of known and new transcript variants of the SETMAR (Metnase) gene and the expression profile in hematologic neoplasms. Experimental Hematology. 42(6). 448–456.e4. 14 indexed citations
9.
Ommen, Hans Beier, Anni Aggerholm, Birgitte Lausen, et al.. (2011). Genetic and epigenetic similarities and differences between childhood and adult AML. Pediatric Blood & Cancer. 58(4). 525–531. 31 indexed citations
10.
Aggerholm, Anni, et al.. (2009). The combined expression of HOXA4 and MEIS1 is an independent prognostic factor in patients with AML. European Journal Of Haematology. 83(5). 439–448. 28 indexed citations
12.
Jakobsen, Martin R., et al.. (2009). Pre-Screening HIV-1 Reverse Transcriptase Resistance Mutations in Subtype B Patients Using a Novel Multiplex Primer Extension Assay. Current HIV Research. 7(4). 398–409. 2 indexed citations
13.
Olesen, Lene, et al.. (2008). Gene expression profiling of Polycomb, Hox and Meis genes in patients with acute myeloid leukaemia. European Journal Of Haematology. 81(2). 112–122. 70 indexed citations
14.
Aggerholm, Anni, et al.. (2006). A pharmacodynamic study of 5-azacytidine in the P39 cell line. Experimental Hematology. 34(1). 35–43. 17 indexed citations
16.
Aggerholm, Anni, Mette Skov Holm, Per Guldberg, Lene Olesen, & Peter Hokland. (2005). Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early‐stage patients. European Journal Of Haematology. 76(1). 23–32. 143 indexed citations
17.
Olesen, Lene, Anni Aggerholm, Charlotte Guldborg Nyvold, et al.. (2005). Molecular typing of adult acute myeloid leukaemia: significance of translocations, tandem duplications, methylation, and selective gene expression profiling. British Journal of Haematology. 131(4). 457–467. 29 indexed citations
18.
Olesen, Lene, Charlotte Guldborg Nyvold, Anni Aggerholm, et al.. (2005). Delineation and molecular characterization of acute myeloid leukemia patients with coduplication of FLT3 and MLL. European Journal Of Haematology. 75(3). 185–192. 12 indexed citations
19.
Aggerholm, Anni, Kirsten Grønbæk, Per Guldberg, & Peter Hokland. (2000). Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders. European Journal Of Haematology. 65(2). 109–113. 59 indexed citations
20.
Guldberg, Per, Kirsten Grønbæk, Anni Aggerholm, et al.. (1998). Detection of mutations in GC-rich DNA by bisulphite denaturing gradient gel electrophoresis. Nucleic Acids Research. 26(6). 1548–1549. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026